| Literature DB >> 29116012 |
Haiyun Pei1,2, Chao Zhai1, Huilin Li1, Fang Yan3, Jinhua Qin1,3,2, Hongfeng Yuan1, Rui Zhang1, Shuyong Wang1,3,2, Wencheng Zhang1, Mingyang Chang3, Yunfang Wang4, Xuetao Pei5,6.
Abstract
BACKGROUND: Bi-potential hepatic progenitor cells can give rise to both hepatocytes and cholangiocytes, which is the last phase and critical juncture in terms of sequentially hepatic lineage restriction from any kind of stem cells. If their differentiation can be controlled, it might access to functional hepatocytes to develop pharmaceutical and biotechnology industries as well as cell therapies for end-stage liver diseases.Entities:
Keywords: Cell therapy; Connexin; Differentiation; Hepatic progenitor cell; Hepatocyte; p38 MAPK
Mesh:
Substances:
Year: 2017 PMID: 29116012 PMCID: PMC5678556 DOI: 10.1186/s13287-017-0703-2
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Primers used for real-time PCR
| Rat-Cx43-S | TCTGCCTTTCGCTGTAACACT |
|---|---|
| Rat-Cx43-AS | GGGCACAGACACGAATATGAT |
| Rat-CX32-S | CCAGGGCTCAAGGTTATTGA |
| Rat-CX32-AS | TCTCCATCCACAGTGCAGAG |
| Rat-Afp-S | ACCTGACAGGGAAGATGGTG |
| Rat-Afp-AS | GCAGTGGTTGATACCGGAGT |
| Rat-Alb-S | AATTGGCAACAGACCTCACC |
| Rat-Alb-AS | GCACTGGCTTATCACAGCAA |
| Rat-CYP1B1-S | CCCGTGGTGGTGCTGAAT |
| Rat-CYP1B1-AS | AAAGAGGCGAAGGGAGGC |
| Rat-CK18-S | TTTGCGAATTCTGTGGACAA |
| Rat-CK18-AS | ACCTCGTGATGTTGGTGTCA |
| Rat-CK19-S | CCACACTACGCAGATCCAGA |
| Rat-CK19-AS | ATGCTGAGCTGAGACTGCAA |
| Rat-Hnf1a-S | ACCAGTCCCACAGTGTCCTC |
| Rat-Hnf1a-AS | GCCATCTGGGTGGAGATAAA |
| Rat-Hnf4a-S | AAATGTGCAGGTGTTGACCA |
| Rat-Hnf4a-AS | CACGCTCCTCCTGAAGAATC |
| Rat-Ggt4-S | GTCACCAACTTCAACTCTGC |
| Rat- Ggt4-AS | CCTTATCACTGTTTACCTCGG |
| Rat-Hnf6-S | GAAAATAAGCGTCCGTCCAAAG |
| Rat-Hnf6-AS | CTGGCATTCATGAAGAAGTTGC |
| Rat-GAPDH-S | TGCCACTCAGAAGACTGTGG |
| Rat-GAPDH-AS | TTCAGCTCTGGGATGACCTT |
S sense, AS anti-sense
Fig. 1The expression pattern of Cxs in differentiation of WB cells. a Representative images of WB cells, hepatocytes (WB-Hep) and biliary epithelial cells (WB-BEC) differentiated from WB cells. b qRT-PCR analysis of hepatic and biliary markers in WB-Hep and WB-BEC. c Immunostaining of Cx32 and Cx43 in WB cells and WB-Hep. d Western blotting of hepatic markers in WB cells and WB-Hep; β-actin was used as an internal control. Scale bars:100 μm for A and 50 μm for C. Data represented as mean ± SEM. * p < 0.05, ** p < 0.01
Fig. 2Hepatocyte differentiation from hepatic progenitor cells was affected by Cxs expression. a Overexpression of Cx32 and Cx43, and knockdown of Cx43 in WB cells were confirmed by Western blotting. b qRT-PCR analysis of hepatic markers in cells differentiated from WB cells with Cx32 or Cx43 overexpression, or Cx43 knockdown. c Western blotting of hepatic markers in cells differentiated from WB cells with Cx32 or Cx43 overexpression, or Cx43 knockdown. d ICG uptake. e Urea production of WB cells with Cx32 or Cx43 overexpression, 2APB, or Cx43 knockdown. Scale bars: 100 μm. Data represented as mean ± SEM. * p < 0.05, ** p < 0.01
Fig. 3p38 MAPK pathway affected hepatocytes differentiation associating with downregulation of Cx43 and upregulation of Cx32. a Western blotting of phospho-p38 (P-p38) and total p38 in WB cells and WB-Hep. b qRT-PCR analysis of WB-Hep induced with or without SB203580 treatment. c Western blotting of WB-Hep induced with or without SB203580 treatment. d qRT-PCR analysis of WB-Hep induced with SB203580 from WB cells and Cx43-overexpressed WB cells. e Western blotting of WB-Hep induced with SB203580 from WB cells and Cx43-overexpressed WB cells. f Cell viability test by CCK8. g Flow cytometry analysis of apoptosis. h ICG uptake. i Induction of CYP3A4 activity in response to 72 hours of stimulation with PXR agonist rifampicin. Data represented as mean ± SEM. * p < 0.05, ** p < 0.01
Fig. 4p38 MAPK pathway and expression level of Cxs have an effect on Hnf1a and Hnf4a in differentiation of hepatic progenitors. a qRT-PCR analysis of Hnf1a and Hnf4a expression in WB-Hep at day 5 and day 10 induced from WB cells with Cx32 or Cx43 overexpression, or Cx43 knockdown. b qRT-PCR analysis of Hnf1a and Hnf4a expression in WB cells and WB-Hep induced with or without SB203580 treatment. Data represented as mean ± SEM. * p < 0.05, ** p < 0.01
Fig. 5p38 MAPK pathway affects differentiation of fetal rat hepatic progenitor cells. a qRT-PCR analysis of fetal rat hepatic progenitor cells and their derivation with or without SB203580 treatment. b Western blotting analysis of rat hepatic progenitor cells and their derivation with or without SB203580 treatment. Data represented as mean ± SEM. * p < 0.05, ** p < 0.01